The content on this site is intended for healthcare professionals only
Dr Murrell and Dr Pardo discuss and answer questions about their presentations on epigenetics and metabolomics at the Future Horizons in Lung Cancer meeting.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Social determinants and survival outcomes in early-onset colorectal cancer in the US
The added value of integrative medicine
Insights into germline genetic screening of breast cancer patients
New classification for identifying HR myeloma based on cytogenetic abnormalities
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
GIST tumours and soft tissue sarcomas
